(Q40336358)

19 September 2017

A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

19 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Gang Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Alan C-Y Hsu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Irwan Hanish

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Peter Wark

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

M R Starkey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

P M Nair

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

S Pavlidis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

D H Nguyen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

R Y Kim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

A M Collison

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

M D Inman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

P S Foster

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

D A Knight

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

J Mattes

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

H Yagita

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

I M Adcock

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

J C Horvat

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

P M Hansbro

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

11 November 2015

1 reference

19 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

859-872

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/mi.2015.111

6 June 2020

exact match

0 references

cites work

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Pulmonary-intestinal cross-talk in mucosal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic obstructive pulmonary disease and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Antagonism of miR-328 increases the antimicrobial function of macrophages and neutrophils and rapid clearance of non-typeable Haemophilus influenzae (NTHi) from infected lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Recent advances in pre-clinical mouse models of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

miR-638 regulates gene expression networks associated with emphysematous lung destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Down-regulation of the notch pathway in human airway epithelium in association with smoking and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Cigarette smoke-induced accumulation of lung dendritic cells is interleukin-1α-dependent in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Innate cellular sources of interleukin-17A regulate macrophage accumulation in cigarette- smoke-induced lung inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Chemokine expression by small sputum macrophages in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Elevated MMP-12 protein levels in induced sputum from patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Serum amyloid A promotes lung neutrophilia by increasing IL-17A levels in the mucosa and γδ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

The emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Increased p53 level, Bax/Bcl-x(L) ratio, and TRAIL receptor expression in human emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

TRAIL regulates collagen production through HSF1-dependent Hsp47 expression in activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

TRAIL and its receptors as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

CD8 T cells utilize TRAIL to control influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Women and lung disease. Sex differences and global health disparities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Animal models of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.111

Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease

21 January 2018

1 reference

12 December 2020

A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK

1 reference

12 December 2020

Neutralizing Granulocyte/Macrophage Colony–Stimulating Factor Inhibits Cigarette Smoke–induced Lung Inflammation

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease

1 reference

12 December 2020

Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease

1 reference

12 December 2020

Pressure-volume curves of the respiratory system.

1 reference

12 December 2020

Identifiers

DOI

10.1038/MI.2015.111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26555706%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference